Loading…
Sensei Biotherapeutics Inc is projected to rise to $19.60 by 2027, a +42% move from its current price of $13.85. SNSE is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $12.82 | $13.84 | $14.94 | -0.09% |
| Jul 14 | $12.41 | $13.82 | $15.40 | -0.18% |
| Jul 15 | $12.10 | $13.81 | $15.77 | -0.27% |
| Jul 16 | $11.84 | $13.80 | $16.08 | -0.36% |
| Jul 17 | $11.62 | $13.79 | $16.36 | -0.45% |
| Jul 18 | $11.42 | $13.78 | $16.61 | -0.54% |
| Jul 19 | $11.24 | $13.76 | $16.85 | -0.63% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $11.24 | $13.76 | $16.85 | -0.63% |
| Week 2 | $10.27 | $13.68 | $18.21 | -1.26% |
| Week 3 | $9.57 | $13.59 | $19.29 | -1.88% |
| Week 4 | $9.01 | $13.50 | $20.24 | -2.50% |
| Week 5 | $8.54 | $13.42 | $21.09 | -3.11% |
| Week 6 | $8.12 | $13.33 | $21.89 | -3.73% |
| Week 7 | $7.76 | $13.25 | $22.63 | -4.33% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Sensei Biotherapeutics, Inc. is a clinical-stage biotechnology company in the healthcare sector that engages in the discovery and development of therapeutics for cancer patients. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.
The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors.
The company’s pipeline includes SNS-102 and SNS-103, an active monoclonal antibody, which are in early development stages for the treatment of solid tumors, as well as SNS-201 is a bispecific antibody targeting CD28. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc.
was incorporated in 1999 and is headquartered in Rockville, Maryland.
Sensei Biotherapeutics, Inc. (SNSE) trades as a healthcare stock with a current price of $13.00 per share and a market capitalization of $17.45M. It is ranked 4900 in market listings.
The stock’s current positioning is complemented by a 30-day price range of $7.74 to $21.83, illustrating notable intrarange movement in a small-cap biotech context.
A major floor 61.3% below — a decisive break under it would weaken the trend.
The nearest floor, 22.1% below — buyers have tended to step in here.
The nearest ceiling, 80.5% above — a clean break opens room to run.
A major ceiling 153.2% above — clearing it would confirm fresh momentum.
Key SNSE support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SNSE market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $23.53 | Sell | $23.38 | Sell |
| MA 10 | $23.20 | Sell | $22.31 | Sell |
| MA 20 | $18.49 | Sell | $20.71 | Sell |
| MA 50 | $21.01 | Sell | $20.98 | Sell |
| MA 100 | $24.44 | Sell | $20.86 | Sell |
| MA 200 | $17.09 | Sell | $18.37 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 57.36 | Neutral |
| Stoch RSI (14) | 71.28 | Neutral |
| CCI (20) | 61.83 | Neutral |
| Williams %R (14) | -17.33 | Info |
| MACD (12,26,9) | 0.89 | Buy |
| ROC (12) | 65.49 | Buy |
| Bollinger %B (20,2) | 0.72 | Neutral |
| Stochastic %K (14) | 82.67 | Sell |
| TRIX (15) | 0.30 | Buy |
| Awesome (5,34) | 5.21 | Buy |
| Ultimate (7,14,28) | 55.10 | Neutral |
| Momentum (10) | 5.66 | Buy |
| Aroon Osc (25) | 48.00 | Buy |
| Hull MA (9) | 23.80 | Sell |
| ADX (14) | 25.71 | Buy |
| ATR (14) | 1.29 | Info |
The sentiment rating is NEUTRAL with RSI14 at 40.00. The stock is shown with a SMA50 of $23.38 and a SMA200 of $16.26, indicating price dynamics around key moving averages.
Support is listed at $10.79 and resistance at $26.96, framing potential trade levels. The 30-day range spans from $7.74 to $21.83, reflecting recent volatility. Annualized volatility stands at 200%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $8.75 | $13.85 | $17.23 | 0% | Neutral | |
| $14.21 | $19.60 | $29.22 | +42% | Bullish | |
| $14.04 | $20.57 | $32.67 | +49% | Bullish | |
| $12.66 | $19.53 | $32.57 | +41% | Bullish | |
| $11.30 | $18.29 | $31.75 | +32% | Bullish | |
| $10.80 | $18.26 | $32.82 | +32% | Bullish | |
| $11.81 | $20.83 | $38.59 | +50% | Bullish | |
| $13.91 | $25.55 | $48.65 | +84% | Bullish | |
| $15.96 | $30.49 | $59.53 | +120% | Bullish | |
| $15.19 | $30.17 | $60.27 | +118% | Bullish | |
| $21.43 | $47.61 | $104.53 | +244% | Bullish | |
| $23.93 | $53.19 | $122.33 | +284% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $8.75 | $13.85 | $17.42 | +0.00% |
| August 2026 | $10.95 | $13.28 | $16.78 | -4.11% |
| September 2026 | $10.37 | $12.75 | $16.45 | -3.97% |
| October 2026 | $10.85 | $13.50 | $17.71 | +5.83% |
| November 2026 | $10.72 | $13.48 | $17.94 | -0.13% |
| December 2026 | $10.06 | $12.78 | $17.23 | -5.21% |
Click any year to see its month-by-month SNSE forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Sensei Biotherapeutics Inc's 2026 outlook centres on $13.85, within a $8.75 to $17.23 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, SNSE could reach as high as $29.22, with a base case around $19.60 and support toward $14.21 — roughly +42% from $13.85. Buyers look set to stay in control over this stretch.
Expect SNSE to range from $14.04 to $32.67 through 2028. The $20.57 average target implies a +49% move from current prices. That is up +5% on the projected 2027 average. Momentum favours further upside here.
The SNSE price prediction for 2029 points to an average of $19.53 (low $12.66, high $32.57) — a potential gain of +41% on today's $13.85. Buyers look set to stay in control over this stretch.
In 2030, SNSE is projected to trade between $11.30 and $31.75, averaging $18.29 — a potential gain of +32% from today's $13.85. That is -6% versus the projected 2029 average. Momentum favours further upside here.
Sensei Biotherapeutics Inc's 2031 outlook centres on $18.26, within a $10.80 to $32.82 range. That is 0% versus the projected 2030 average. That marks a +32% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, SNSE could reach as high as $38.59, with a base case around $20.83 and support toward $11.81 — roughly +50% from $13.85. Momentum favours further upside here.
Expect SNSE to range from $13.91 to $48.65 through 2033. The $25.55 average target implies a +84% move from current prices. That is up +23% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The SNSE price prediction for 2034 points to an average of $30.49 (low $15.96, high $59.53) — a potential gain of +120% on today's $13.85. Momentum favours further upside here.
In 2035, SNSE is projected to trade between $15.19 and $60.27, averaging $30.17 — a potential gain of +118% from today's $13.85. That is -1% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
Sensei Biotherapeutics Inc's 2040 outlook centres on $47.61, within a $21.43 to $104.53 range. That is up +58% on the projected 2035 average. That marks a +244% change versus current levels. Momentum favours further upside here.
By 2050, SNSE could reach as high as $122.33, with a base case around $53.19 and support toward $23.93 — roughly +284% from $13.85. Buyers look set to stay in control over this stretch.
Investing $1,000 in SNSE today (≈ 72.202166 SNSE) could be worth
$3,840.22
+$2,840.22 (+284%) by 2050 · US Dollar
Based on the average projected SNSE price of $53.19 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SNSEwould be worth at today's price.
$1,000 invested in SNSE on Jul 2, 2025 (≈ 107.933077 SNSE) would be worth
$1,494.87
+$494.87 (+49.5%) today · 1.49× · US Dollar
Based on a SNSE entry price of $9.27 vs. today's $13.85.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $24.67 | $561.41 | -43.9% |
| 1 month ago | $16.09 | $860.52 | -13.9% |
| 3 months ago | $31.02 | $446.49 | -55.4% |
| 6 months ago | $9.65 | $1,435.98 | +43.6% |
| 1 year ago | $9.27 | $1,494.87 | +49.5% |
| All time (5.0y) ago | $155.2 | $89.24 | -91.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SNSE forecast.
Our base-case forecast reaches $28.00 around 2034.
Implied market cap at $28.00: $37.57M
The multi-year forecast depicts a bullish trajectory with rising averages and meaningful upside over time. In 2027, the avg price is $18.57 with an ROI of 42.9% and a bullish sentiment, followed by 2028 at $17.47 avg with a 34.4% ROI and bullish sentiment, and 2029 at $17.47 avg with a 34.4% ROI and bullish sentiment.
In 2030 the avg is $17.38 with a 33.7% ROI and bullish sentiment, while 2031 shows a softer path at $14.79 avg with a 13.8% ROI and neutral sentiment. The forecast extends into 2032–2035 with continued upside: 2032 avg $17.41 (33.9% ROI, bullish), 2033 avg $21.83 (67.9% ROI, bullish), 2034 avg $24.37 (87.4% ROI, bullish), and 2035 avg $26.06 (100.5% ROI, bullish).
Longer-term horizons show stronger upside: 2040 avg $35.87 (175.9% ROI, bullish) and 2050 avg $42.67 (228.2% ROI, bullish). The implied price ranges broaden in later years with 2033 max $41.65, 2034 max $47.66, 2035 max $52.15, 2040 max $78.84, and 2050 max $98.13. These are estimates, not guarantees.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $17.38 with a range from $10.71 to $30.26 and an ROI of 33.7%. The sentiment is bullish for 2030.
The forecast indicates a mix of neutral to bullish outlook across years, with 2026 neutral (avg $13.00, ROI 0%) and several years bullish (e.g., 2027 avg $18.57, ROI 42.9%; 2040 avg $35.87, ROI 175.9%; 2050 avg $42.67, ROI 228.2%). These are estimates and not guarantees.
The maximum forecasted price is $98.13 in 2050, with higher year maxima including $87.66? actual listed maxes are $98.13 for 2050, and earlier years have lower maxima (for example, 2035 max $52.15). The data point closest to $100 is 2050 with $98.13 max.
$.17.45M
Sensei Biotherapeutics Inc Community Discussion
0Share your Sensei Biotherapeutics Inc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.